Mind Club

Data as of 11.07.2026 · Primary sources linked · NOT INVESTMENT ADVICE

Disease Pipeline Tools Obesity

Obesity

Programs, trials, and reported weight change for obesity and overweight.

Data as of 11.07.2026

All studies

Liraglutide

SAXAPCOS

Novo Nordisk · Phase 3 · Completed · Enrollment 88

NCT03480022

ArmNauseaVomitingDiarrheaDiscontinuationDeaths
Liraglutide Pen Injector (Saxenda)14 participants5 participants4 participantsn/r0
Placebo liraglutide pen injector3 participants0 participants0 participantsn/r0

A count stays a count. This page does not turn a count into a percent.